The c.427-2A>G variant in the HNF4A gene, is predicted to remove a canonical splice acceptor site in intron 4 of NM_175914.4. This variant is predicted to cause an in-frame deletion of biologically-relevant exon 5 of 10, removing more than 10% of the protein (PVS1_Strong). This variant was identified in three unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (internal laboratory collaborators, PMID 36504295). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant segregated with diabetes, with three informative meioses in 1 family with MODY (PP1; internal laboratory collaborators). This variant was identified in at least 2 individuals with a clinical history highly specific for HNF4A-MODY (MODY probability calculator result >50%, negative genetic testing for HNF1A, and history of macrosomia and neonatal hypoglycemia) (PP4_Moderate; internal laboratory collaborators). In summary, c.427-2A>G meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.0.0, approved 11/16/2022): PVS1_Strong, PM2_Supporting, PP1, PP4_Moderate.